Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 The effects of bradykinin (0.2, 0.6, 2.0 µg/min), acetylcholine (ACh) (30 µg/min) and papaverine (PA) (12 mg) on tissue plasminogen activator (tPA) antigen in the aorta (Ao) and coronary sinus (CS) in the angiotensin-converting enzyme inhibitor group (open box) and the nonangiotensin-converting enzyme inhibitor group (closed circle). 2 min: 2 min after cessation of the infusion of bradykinin; 4 min: 4 min after cessation of the infusion of bradykinin. *p < 0.05 versus baseline.
|
